93 results
Page 2 of 5
8-K
EX-1.1
5zqit51
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-99.2
vfedv 71tomd2l4d6rs
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
fzuij8 dlssnsd
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
ao05cvzuqew
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
pnn0fhlnja1px mupi
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
d86 pe24i
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
zmkz0zvmx0yqvmu9tqg9
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
qak9az 2mox
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
mqzh9
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
3run4h8130 rc312z
14 Jun 21
Other Events
5:21pm
8-K
EX-10.1
85227 2in
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-4.1
y2nusto62hp3bqx98d
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
oxdqj
18 May 21
Other Events
3:09pm
8-K
EX-99.1
o2gcc 2wxm01jcy9j
8 Dec 20
Regulation FD Disclosure
7:40am
8-K
EX-99.2
y9aqq
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K
EX-10.1
zezxe4i5tol10y h83
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm